CONMED Corp (New York Stock Exchange:CNMD)
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Profitable, but on a thin margin.
- Revenue
- $1.37B
- Net income
- $73.4M
- Net margin
- 5.4%
Heavily indebted for what it earns.
- Total debt
- $815.9M
- Cash
- $48.0M
- Net debt / EBITDA
- 3.63x
Covers near-term obligations, without much room.
- Current assets
- $682.0M
- Current liabilities
- $459.0M
- Current ratio
- 1.49
The business funds itself from operations.
- Operating cash flow
- $146.3M
- Free cash flow
- $132.7M
- FCF margin
- 9.7%
Not funding itself by issuing shares.
- Shares outstanding
- 29.9M
- Share growth (1y)
- -3.3%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CNMD Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 335.56 M | 343.49 M | 317.05 M | 373.47 M | 338.58 M | 343.04 M |
| Revenue Growth (YoY) | -0.89 % | 0.13 % | -0.74 % | 7.96 % | 6.91 % | 3.29 % |
| Cost of Revenue | 146.41 M | 146.03 M | 133.60 M | 160.15 M | 180.62 M | 162.52 M |
| Gross Profit | 189.15 M | 197.46 M | 183.45 M | 213.33 M | 157.96 M | 180.52 M |
| SG&A Expense | 136.42 M | 145.55 M | 141.70 M | 131.56 M | 124.66 M | 124.66 M |
| R&D Expense | 15.59 M | 15.50 M | 16.33 M | 14.90 M | 13.90 M | 14.14 M |
| Operating Expenses | 152.00 M | 161.05 M | 158.03 M | 146.45 M | 138.56 M | 138.80 M |
| Operating Income | 37.14 M | 36.41 M | 25.41 M | 66.87 M | 19.40 M | 41.72 M |
| Pretax Income | 26.01 M | 31.35 M | 18.36 M | 29.25 M | 4.27 M | 29.92 M |
| Tax Provision | 6.21 M | 8.28 M | 4.53 M | 12.51 M | 1.41 M | 8.50 M |
| Net Income | 19.80 M | 23.07 M | 13.83 M | 16.74 M | 2.86 M | 21.42 M |
| EPS (Basic) | 0.66 | 0.77 | 0.45 | 0.54 | 0.09 | 0.69 |
| EPS (Diluted) | 0.66 | 0.77 | 0.45 | 0.54 | 0.09 | 0.69 |
| Shares Outstanding | 29.93 M | 30.07 M | 30.59 M | 30.97 M | 30.95 M | 30.95 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.